HI SB2659

Expands the definition of transdermal products by changing "transdermal patches" to "transdermal devices" in section 329D-10, Hawaii Revised Statutes, to include non-patch devices that deliver cannabinoids through the skin.

Adds "cannabinoid suppositories" as a new authorized medical cannabis product type, defined as soluble containers designed to melt at body temperature and deliver cannabinoid products through rectal or vaginal administration.

Simplifies the definition of "manufactured cannabis product" to broadly reference any product manufactured using cannabis pursuant to section 329D-10, rather than listing specific product types.

Allows dispensaries to manufacture and distribute the newly added suppository products alongside existing approved forms such as capsules, oils, tinctures, ointments, and aerosolized delivery devices.

Effective date set for July 1, 3000.